118 related articles for article (PubMed ID: 12716366)
1. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma.
Hamada M; Yakushijin Y; Ohtsuka M; Kakimoto M; Yasukawa M; Fujita S
Br J Haematol; 2003 May; 121(3):439-47. PubMed ID: 12716366
[TBL] [Abstract][Full Text] [Related]
2. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers.
Miyoshi Y; Iwao K; Egawa C; Noguchi S
Int J Cancer; 2001 May; 92(3):370-3. PubMed ID: 11291073
[TBL] [Abstract][Full Text] [Related]
3. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.
Zhou H; Kuang J; Zhong L; Kuo WL; Gray JW; Sahin A; Brinkley BR; Sen S
Nat Genet; 1998 Oct; 20(2):189-93. PubMed ID: 9771714
[TBL] [Abstract][Full Text] [Related]
4. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.
Hu W; Kavanagh JJ; Deaver M; Johnston DA; Freedman RS; Verschraegen CF; Sen S
Oncol Res; 2005; 15(1):49-57. PubMed ID: 15839305
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
6. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.
Fraizer GC; Diaz MF; Lee IL; Grossman HB; Sen S
Int J Oncol; 2004 Dec; 25(6):1631-9. PubMed ID: 15547700
[TBL] [Abstract][Full Text] [Related]
7. Targeting aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug design.
Vankayalapati H; Bearss DJ; Saldanha JW; Muñoz RM; Rojanala S; Von Hoff DD; Mahadevan D
Mol Cancer Ther; 2003 Mar; 2(3):283-94. PubMed ID: 12657723
[TBL] [Abstract][Full Text] [Related]
8. Amplification/overexpression of a mitotic kinase gene in human bladder cancer.
Sen S; Zhou H; Zhang RD; Yoon DS; Vakar-Lopez F; Ito S; Jiang F; Johnston D; Grossman HB; Ruifrok AC; Katz RL; Brinkley W; Czerniak B
J Natl Cancer Inst; 2002 Sep; 94(17):1320-9. PubMed ID: 12208897
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.
Li D; Zhu J; Firozi PF; Abbruzzese JL; Evans DB; Cleary K; Friess H; Sen S
Clin Cancer Res; 2003 Mar; 9(3):991-7. PubMed ID: 12631597
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase.
Sun C; Newbatt Y; Douglas L; Workman P; Aherne W; Linardopoulos S
J Biomol Screen; 2004 Aug; 9(5):391-7. PubMed ID: 15296638
[TBL] [Abstract][Full Text] [Related]
11. Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle.
Katayama H; Zhou H; Li Q; Tatsuka M; Sen S
J Biol Chem; 2001 Dec; 276(49):46219-24. PubMed ID: 11551964
[TBL] [Abstract][Full Text] [Related]
12. Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer.
Gerlach U; Kayser G; Walch A; Hopt U; Schulte-Mönting J; Werner M; Lassmann S
J Pathol; 2006 Mar; 208(4):462-72. PubMed ID: 16402339
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.
Tanaka E; Hashimoto Y; Ito T; Okumura T; Kan T; Watanabe G; Imamura M; Inazawa J; Shimada Y
Clin Cancer Res; 2005 Mar; 11(5):1827-34. PubMed ID: 15756006
[TBL] [Abstract][Full Text] [Related]
14. Expression of serine threonine kinase 15 is associated with poor differentiation in lung squamous cell carcinoma and adenocarcinoma.
Xu HT; Ma L; Qi FJ; Liu Y; Yu JH; Dai SD; Zhu JJ; Wang EH
Pathol Int; 2006 Jul; 56(7):375-80. PubMed ID: 16792546
[TBL] [Abstract][Full Text] [Related]
15. Overexpression and amplification of Aurora-A in hepatocellular carcinoma.
Jeng YM; Peng SY; Lin CY; Hsu HC
Clin Cancer Res; 2004 Mar; 10(6):2065-71. PubMed ID: 15041727
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible enhancer/alpha-fetoprotein promoter-driven RNA interference targeting STK15 suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Gao P; Wang R; Shen JJ; Lin F; Wang X; Dong K; Zhang HZ
Cancer Sci; 2008 Nov; 99(11):2209-17. PubMed ID: 18803637
[TBL] [Abstract][Full Text] [Related]
17. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast.
Hoque A; Carter J; Xia W; Hung MC; Sahin AA; Sen S; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1518-22. PubMed ID: 14693746
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.
Wang X; Zhou YX; Qiao W; Tominaga Y; Ouchi M; Ouchi T; Deng CX
Oncogene; 2006 Nov; 25(54):7148-58. PubMed ID: 16715125
[TBL] [Abstract][Full Text] [Related]
19. STK15 gene overexpression, centrosomal amplification, and chromosomal instability in the absence of STK15 mutations in laryngeal carcinoma.
Li Y; Li F; Li-Ling J; Wang X; Xu Z; Sun K
Cancer Invest; 2005; 23(8):660-4. PubMed ID: 16377583
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.
Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY
Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
